Stay updated on Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial
Sign up to get notified when there's something new on the Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial page.

Latest updates to the Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov website revision identifier in the footer changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check10 days agoChange DetectedThe clinical trial record for NCT02210559 is now displayed, with details on the study design, treatments, eligibility, participating locations, and reported outcome measures.SummaryDifference58%

- Check17 days agoChange DetectedThe footer displays a newer ClinicalTrials.gov site revision, changing from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check31 days agoChange DetectedAn NIH-wide notice about a website transition and terminology appears above the page, and the site revision advances from v3.7.1 to v3.7.2. The study record itself remains inaccessible behind a 403 error.SummaryDifference1%

- Check45 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1; the study record page still displays a 403 error.SummaryDifference0.2%

- Check59 days agoChange DetectedThe study page now renders a 403 Forbidden error with a minimal header and a Home link. This replaces the previous study details and navigation elements.SummaryDifference19%

Stay in the know with updates to Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial page.